Butanoic acid,1,1',1''-[(2R,3R,4R,5S)-1-butyl-2-[(1-oxobutoxy)methyl]-3,4,5-piperidinetriyl]ester

Modify Date: 2024-04-03 09:57:55

Butanoic acid,1,1',1''-[(2R,3R,4R,5S)-1-butyl-2-[(1-oxobutoxy)methyl]-3,4,5-piperidinetriyl]ester structure	Common Name	Butanoic acid,1,1',1''-[(2R,3R,4R,5S)-1-butyl-2-[(1-oxobutoxy)methyl]-3,4,5-piperidinetriyl]ester
	CAS Number	131262-82-3	Molecular Weight	499.63700
	Density	1.09g/cm3	Boiling Point	524ºC at 760mmHg
	Molecular Formula	C₂₆H₄₅NO₈	Melting Point	N/A
	MSDS	N/A	Flash Point	270.7ºC

Name	[(2R,3R,4R,5S)-3,4,5-tri(butanoyloxy)-1-butylpiperidin-2-yl]methyl butanoate
Synonym	More Synonyms

Density	1.09g/cm3
Boiling Point	524ºC at 760mmHg
Molecular Formula	C₂₆H₄₅NO₈
Molecular Weight	499.63700
Flash Point	270.7ºC
Exact Mass	499.31500
PSA	108.44000
LogP	3.88760
Vapour Pressure	4.48E-11mmHg at 25°C
Index of Refraction	1.488

CHEMICAL IDENTIFICATION

RTECS NUMBER :: EK7713970

CHEMICAL NAME :: Butanoic acid, 1-butyl-2-((1-oxobutoxy)methyl)-3,4,5-piperidinetriyl ester, (2R-(2alpha,3beta,4alpha,5beta))-

CAS REGISTRY NUMBER :: 131262-82-3

LAST UPDATED :: 199801

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C26-H45-N-O8

MOLECULAR WEIGHT :: 499.72

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 103 gm/kg/4W-I

TOXIC EFFECTS :: Gastrointestinal - changes in structure or function of salivary glands Gastrointestinal - changes in structure or function of endocrine pancreas Gastrointestinal - other changes

REFERENCE :: TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 24,531,1996

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 218 gm/kg/26W-I

TOXIC EFFECTS :: Gastrointestinal - changes in structure or function of endocrine pancreas Gastrointestinal - other changes Endocrine - other changes

REFERENCE :: TOPADD Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978- Volume(issue)/page/year: 24,531,1996

Perbutylated-N-butyl-1-deoxynojiromycin

N-Butyl DNJ Prodrug

Glycovir

DRG-0193

Butanoic acid,1-butyl-2-((1-oxobutoxy)methyl)-3,4,5-piperidinetriyl ester,(2R-(2alpha,3beta,4alpha,5beta))

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.